GSTM1 and anemia: However, on April 12, 2024, clinical deterioration was evidenced by the onset of fatigue and laboratory findings demonstrating anemia (Hb: 87g/L) and significant hyperbilirubinemia (TBIL: 81.4μmol/L, IBIL: 34.6μmol/L, DBIL: 46.8μmol/L).